Search
Blog Post
Esophageal cancer Q&A with Dr. Fountzilas
Blog Post
Can you have liver cancer and not know it?
… that is significantly damaged,” according to Christos Fountzilas, MD, FACP , Assistant Professor of GI Medical … fluke is a common cause of liver cancer, according to Dr. Fountzilas. More commonly, however, tumors or cancer in the … liver cancer. Learn More How to avoid liver cancer Dr. Fountzilas recommends taking measures to avoid organ damage …
Blog Post
New options for KRAS-associated cancers available at Roswell Park
Clinical Trial
A Phase 1 First-in-human Study of BMS-986500 as Monotherapy in Advanced Solid Tumors and as Combination Therapy in CDK4/6 Inhibitor Pre-treated Advanced Breast Cancer
… in CDK4/6 Inhibitor Pre-treated Advanced Breast Cancer I Fountzilas, Christos The purpose of this study is to assess …
Clinical Trial
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor…
… (FGFR)-altered, Chemotherapy- and FGFR Inhibitor… III Fountzilas, Christos This study is a Phase III, Randomized, …
Blog Post
What's New in Pancreatic Cancer Research?
… to treat it. “We should always have hope,” says Christos Fountzilas, MD, FACP , Department of Medical Oncology at … existing therapy. Some of the latest developments that Dr. Fountzilas considers exciting are new agents that target the … efforts from basic and clinical cancer researchers, Dr. Fountzilas explains. “Blocking a single pathway is not …
Clinical Trial
HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects with Locally Advanced or Metastatic Solid Tumors
Blog Post
Can a commonly prescribed blood pressure drug improve survival for patients with esophageal cancer?
… and radiation in those patients,” says Christos Fountzilas, MD, FACP , Co-Leader of the Gastrointestinal … Early Phase Clinical Trials Program at Roswell Park. Dr. Fountzilas was co-author of an article in the journal Lancet … cancer.” 04/03/2023 - 12:29 Esophageal cancer Q&A with Dr. Fountzilas New immunotherapy-based treatments for esophageal …
Clinical Trial
A Phase I Study of Trifluridine/ Tipiracil plus the Poly (ADP) Ribose Polymerase Inhibitor Talazoparib in Advanced Cancers
Clinical Trial
A Phase 2 Clinical Trial of Nalirifox as Neoadjuvant Treatment for Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
… Borderline Resectable Pancreatic Ductal Adenocarcinoma II Fountzilas, Christos This phase II trial tests how well …